Pulmonary embolism differential diagnosis: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
|- | |- | ||
| [[File:Siren.gif | | <figure-inline>[[File:Siren.gif|link=Pulmonary embolism resident survival guide|41x41px]]</figure-inline>|| <br> || <br> | ||
| [[Pulmonary embolism resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | | [[Pulmonary embolism resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | ||
|} | |} | ||
Line 13: | Line 13: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
===Differential Diagnosis Based on Symptoms=== | ===Differential Diagnosis Based on Symptoms=== | ||
Pulmonary embolism (PE) should be differentiated from other diseases presenting with chest pain, shortness of breath and tachypnea. The differentials include the following: | Pulmonary embolism (PE) should be differentiated from other diseases presenting with [[chest pain]], [[shortness of breath]] and [[tachypnea]]. The differentials include the following: | ||
<small> | <small> | ||
{| | {| | ||
|-style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan="2" |<small>Diseases</small> | ! rowspan="2" |<small>Diseases</small> | ||
! colspan="3" |<small>Diagnostic tests</small> | ! colspan="3" |<small>Diagnostic tests</small> | ||
Line 56: | Line 56: | ||
| style="background: #F5F5F5; padding: 5px;" |✔ (In case of massive PE) | | style="background: #F5F5F5; padding: 5px;" |✔ (In case of massive PE) | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Hypercoagulating conditions (Factor V Leiden, thrombophilia, deep vein thrombosis, immobilization, malignancy, pregnancy) | *Hypercoagulating conditions (Factor V Leiden, thrombophilia, deep vein thrombosis, immobilization, malignancy, pregnancy) | ||
Line 66: | Line 66: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Congestive heart failure]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Congestive heart failure]] | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*On CT scan: | *On CT scan: | ||
** Mediastinal lymphadenopathy | ** Mediastinal lymphadenopathy | ||
Line 74: | Line 74: | ||
** Delayed enhancement MRI may help characterize the myocardial tissue (fibrosis) | ** Delayed enhancement MRI may help characterize the myocardial tissue (fibrosis) | ||
** Late enhancement of contrast in conditions such as myocarditis, sarcoidosis, amyloidoisis, Anderson-Fabry's disease, Chagas' disease) | ** Late enhancement of contrast in conditions such as myocarditis, sarcoidosis, amyloidoisis, Anderson-Fabry's disease, Chagas' disease) | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity) | *Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity) | ||
**SV1 or SV2 + RV5 or RV6 ≥3.5 mV | **SV1 or SV2 + RV5 or RV6 ≥3.5 mV | ||
**Total QRS amplitude in each of the limb leads ≤0.8 mV | **Total QRS amplitude in each of the limb leads ≤0.8 mV | ||
** R/S ratio <1 in lead V4 | ** R/S ratio <1 in lead V4 | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Cardiomegaly | *Cardiomegaly | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Previous myocardial infarction | *Previous myocardial infarction | ||
Line 107: | Line 107: | ||
**Eventual right heart faliure | **Eventual right heart faliure | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Percarditis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Percarditis]] | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*On contrast enhanced CT scan: | *On contrast enhanced CT scan: | ||
**Enhancement of the pericardium (due to inflammation) | **Enhancement of the pericardium (due to inflammation) | ||
Line 116: | Line 116: | ||
**Pericardial enhancement (due to inflammation) | **Pericardial enhancement (due to inflammation) | ||
**Pericardial effusion | **Pericardial effusion | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*ST elevation | *ST elevation | ||
*PR depression | *PR depression | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Large collection of fluid inside the pericardial sac (pericardial effusion) | *Large collection of fluid inside the pericardial sac (pericardial effusion) | ||
*Calcification of pericardial sac | *Calcification of pericardial sac | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ (Low grade) | | style="background: #F5F5F5; padding: 5px;" |✔ (Low grade) | ||
|style="background: #F5F5F5; padding: 5px;" |✔ (Relieved by sitting up and leaning forward) | | style="background: #F5F5F5; padding: 5px;" |✔ (Relieved by sitting up and leaning forward) | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Infections: | *Infections: | ||
**Viral (Coxsackie virus, Herpes virus, Mumps virus, HIV) | **Viral (Coxsackie virus, Herpes virus, Mumps virus, HIV) | ||
Line 142: | Line 142: | ||
*Malignancy | *Malignancy | ||
*Previous myocardial infarction | *Previous myocardial infarction | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*May be clinically classified into: | *May be clinically classified into: | ||
**Acute (< 6 weeks) | **Acute (< 6 weeks) | ||
Line 148: | Line 148: | ||
**Chronic (> 6 months) | **Chronic (> 6 months) | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pneumonia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pneumonia]] | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
**On CT scan: (not generally indicated) | **On CT scan: (not generally indicated) | ||
*Consolidation (alveolar/lobar pneumonia) | *Consolidation (alveolar/lobar pneumonia) | ||
Line 158: | Line 158: | ||
**On MRI: | **On MRI: | ||
*Not indicated | *Not indicated | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Prolonged PR interval | *Prolonged PR interval | ||
*Transient T wave inversions | *Transient T wave inversions | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Consolidation (alveolar/lobar pneumonia) | *Consolidation (alveolar/lobar pneumonia) | ||
*Peribronchial nodules (bronchopneumonia) | *Peribronchial nodules (bronchopneumonia) | ||
*Ground-glass opacity (GGO) | *Ground-glass opacity (GGO) | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Ill-contact | *Ill-contact | ||
*Travelling | *Travelling | ||
Line 182: | Line 182: | ||
*Recent hospitalization | *Recent hospitalization | ||
*Chronic obstructive pulmonary disease | *Chronic obstructive pulmonary disease | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Requires sputum stain and culture for diagnosis | *Requires sputum stain and culture for diagnosis | ||
*Empiric management usually started before culture results | *Empiric management usually started before culture results | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vasculitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vasculitis]] | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*On CT scan: (Takayasu arteritis) | *On CT scan: (Takayasu arteritis) | ||
**Vessel wall thickening | **Vessel wall thickening | ||
Line 194: | Line 194: | ||
*On MRI: | *On MRI: | ||
Homogeneous, circumferential vessel wall swelling | Homogeneous, circumferential vessel wall swelling | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Right or left bundle-branch block (Churg-Strauss syndrome) | *Right or left bundle-branch block (Churg-Strauss syndrome) | ||
*Atrial fibrillation (Churg-Strauss syndrome) | *Atrial fibrillation (Churg-Strauss syndrome) | ||
*Non-specific ST segment and T wave changes | *Non-specific ST segment and T wave changes | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Nodules | *Nodules | ||
*Cavitation | *Cavitation | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Takayasu arteritis usually found in persons aged 4-60 years with a mean of 30 | *Takayasu arteritis usually found in persons aged 4-60 years with a mean of 30 | ||
*Giant-cell arteritis usually occurrs in persons aged > 60 years | *Giant-cell arteritis usually occurrs in persons aged > 60 years | ||
*Churg-Strauss syndrome may present with asthma, sinusitis, transient pulmonary infiltrates and neuropathy alongwith cardiac involvement | *Churg-Strauss syndrome may present with asthma, sinusitis, transient pulmonary infiltrates and neuropathy alongwith cardiac involvement | ||
*Granulomatous vasculitides may present with nephtitis and upper airway (nasopharyngeal) destruction | *Granulomatous vasculitides may present with nephtitis and upper airway (nasopharyngeal) destruction | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chronic obstructive pulmonary disease]] (COPD) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chronic obstructive pulmonary disease]] (COPD) | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*On CT scan: | *On CT scan: | ||
**Chronic bronchitis may show bronchial wall thickening, scarring with bronchovascular irregularity, fibrosis | **Chronic bronchitis may show bronchial wall thickening, scarring with bronchovascular irregularity, fibrosis | ||
Line 229: | Line 229: | ||
**Loss of retrosternal airspace due to right ventricular enlargement | **Loss of retrosternal airspace due to right ventricular enlargement | ||
**Hyperpolarized Helium MRI may show progressively poor ventilation and destruction of lung | **Hyperpolarized Helium MRI may show progressively poor ventilation and destruction of lung | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Multifocal atrial tachycardia (atleast 3 distinct P wave morphologies) | *Multifocal atrial tachycardia (atleast 3 distinct P wave morphologies) | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Enlarged lung shadows (emphysema) | *Enlarged lung shadows (emphysema) | ||
*Flattening of diaphragm (emphysema) | *Flattening of diaphragm (emphysema) | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Smoking | *Smoking | ||
*Alpha-1 antitrypsin deficiency | *Alpha-1 antitrypsin deficiency | ||
*Increased sputum production (chronic bronhitis) | *Increased sputum production (chronic bronhitis) | ||
*Cough | *Cough | ||
|style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Alpha 1 antitrypsin deficiency may be associated with hepatomegaly | *Alpha 1 antitrypsin deficiency may be associated with hepatomegaly | ||
|} | |} |
Revision as of 20:41, 13 October 2017
<figure-inline></figure-inline> | Resident Survival Guide |
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism differential diagnosis On the Web |
Directions to Hospitals Treating Pulmonary embolism differential diagnosis |
Risk calculators and risk factors for Pulmonary embolism differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] The APEX Trial Investigators; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Pulmonary embolism must be distinguished from other life-threatening causes of chest pain including acute myocardial infarction, aortic dissection, and pericardial tamponade, as well as a large list of non-life-threatening causes of chest discomfort and shortness of breath.
Differential Diagnosis
Differential Diagnosis Based on Symptoms
Pulmonary embolism (PE) should be differentiated from other diseases presenting with chest pain, shortness of breath and tachypnea. The differentials include the following:
Diseases | Diagnostic tests | Physical Examination | Symptoms | Past medical history | Other Findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CT scan and MRI | EKG | Chest X-ray | Tachypnea | Tachycardia | Fever | Chest Pain | Hemoptysis | Dyspnea on Exertion | Wheezing | Chest Tenderness | Nasalopharyngeal Ulceration | Carotid Bruit | |||
Pulmonary embolism |
|
|
|
✔ | ✔ | ✔ (Low grade) | ✔ | ✔ (In case of massive PE) | ✔ | - | - | - | - |
|
|
Congestive heart failure |
|
|
|
✔ | ✔ | ✔ | - | - | ✔ | - | - | - | - |
|
|
Percarditis |
|
|
|
✔ | ✔ | ✔ (Low grade) | ✔ (Relieved by sitting up and leaning forward) | - | ✔ | - | - | - | - |
|
|
Pneumonia |
|
|
|
✔ | ✔ | ✔ | ✔ | - | ✔ | ✔ | - | - | - |
|
|
Vasculitis |
Homogeneous, circumferential vessel wall swelling |
|
|
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
|
Chronic obstructive pulmonary disease (COPD) |
|
|
|
✔ | ✔ | - | - | - | ✔ | ✔ | - | - | - |
|
|
Life Threatening Differential Diagnosis
Common Differential Diagnosis in Outpatients
Among outpatients presenting with dyspnea, <4 % are diagnosed with PE.[1] Common differential diagnoses include:[1]
Complete List of Differential Diagnosis
- Acute coronary syndrome
- Acute heart failure[1]
- Asthma acute exacerbation
- Acute respiratory distress syndrome
- Anemia
- Angina pectoris
- Anxiety disorders
- Aortic stenosis
- Atrial fibrillation (diagnosis and management)
- Bronchitis
- Cardiogenic shock
- Cardiac tamponade
- Chronic obstructive pulmonary disease exacerbation[1]
- Community acquired pneumonia[1]
- Cor pulmonale
- Costochondritis
- Dilated cardiomyopathy
- Distributive shock
- Emphysema
- Fat embolism
- Hemorrhagic shock
- Herpes zoster
- Hyperventilation
- Mediastinitis
- Mitral stenosis
- Musculoskeletal pain
- Myocardial infarction
- Myocardial ischemia
- Myocarditis
- Noncardiogenic pulmonary edema
- Pericarditis
- Pleuritis
- Pneumonia
- Pneumothorax
- Pulmonary hypertension, primary
- Pulmonary hypertension, secondary
- Restrictive cardiomyopathy
- Rib fracture
- Salicylate intoxication
- Septic shock
- Silicone pulmonary embolism[2]
- Sudden cardiac death
- Superior vena cava syndrome
- Syncope
- Toxic shock syndrome
- Trauma to the chest
- Unstable angina
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Squizzato A, Luciani D, Rubboli A, Di Gennaro L, Gennaro LD, Landolfi R; et al. (2013). "Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms". Intern Emerg Med. 8 (8): 695–702. doi:10.1007/s11739-011-0725-1. PMID 22094406.
- ↑ Restrepo CS, Artunduaga M, Carrillo JA, Rivera AL, Ojeda P, Martinez-Jimenez S; et al. (2009). "Silicone pulmonary embolism: report of 10 cases and review of the literature". J Comput Assist Tomogr. 33 (2): 233–7. doi:10.1097/RCT.0b013e31817ecb4e. PMID 19346851.